HAZELWOOD BLOODSTOCK LIMITED

Company Registration Number:
09858741 (England and Wales)

Unaudited abridged accounts for the year ended 30 November 2024

Period of accounts

Start date: 01 December 2023

End date: 30 November 2024

HAZELWOOD BLOODSTOCK LIMITED

Contents of the Financial Statements

for the Period Ended 30 November 2024

Balance sheet
Notes

HAZELWOOD BLOODSTOCK LIMITED

Balance sheet

As at 30 November 2024


Notes

2024

2023


£

£
Fixed assets
Tangible assets: 3 1,462,725 1,470,548
Total fixed assets: 1,462,725 1,470,548
Current assets
Stocks: 30,600 53,910
Debtors:   420,321 300,219
Cash at bank and in hand: 53,878 68,665
Total current assets: 504,799 422,794
Creditors: amounts falling due within one year:   (185,837) (148,096)
Net current assets (liabilities): 318,962 274,698
Total assets less current liabilities: 1,781,687 1,745,246
Creditors: amounts falling due after more than one year:   (849,186) (868,318)
Total net assets (liabilities): 932,501 876,928
Capital and reserves
Called up share capital: 100 100
Profit and loss account: 932,401 876,828
Shareholders funds: 932,501 876,928

The notes form part of these financial statements

HAZELWOOD BLOODSTOCK LIMITED

Balance sheet statements

For the year ending 30 November 2024 the company was entitled to exemption under section 477 of the Companies Act 2006 relating to small companies.

The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

The members have agreed to the preparation of abridged accounts for this accounting period in accordance with Section 444(2A).

These accounts have been prepared in accordance with the provisions applicable to companies subject to the small companies regime.

The directors have chosen to not file a copy of the company’s profit & loss account.

This report was approved by the board of directors on 10 March 2025
and signed on behalf of the board by:

Name: A O'Brien
Status: Director

The notes form part of these financial statements

HAZELWOOD BLOODSTOCK LIMITED

Notes to the Financial Statements

for the Period Ended 30 November 2024

1. Accounting policies

These financial statements have been prepared in accordance with the provisions of Section 1A (Small Entities) of Financial Reporting Standard 102

HAZELWOOD BLOODSTOCK LIMITED

Notes to the Financial Statements

for the Period Ended 30 November 2024

2. Employees

2024 2023
Average number of employees during the period 6 6

HAZELWOOD BLOODSTOCK LIMITED

Notes to the Financial Statements

for the Period Ended 30 November 2024

3. Tangible Assets

Total
Cost £
At 01 December 2023 1,557,391
Additions 13,509
Disposals (10,000)
At 30 November 2024 1,560,900
Depreciation
At 01 December 2023 86,843
Charge for year 12,827
On disposals (1,495)
At 30 November 2024 98,175
Net book value
At 30 November 2024 1,462,725
At 30 November 2023 1,470,548